Gabriele Peron
Stevanato Group, Italy
Title: Shaping pharma manufacturing facility design through a ready to fill primary packaging solution
Biography
Biography: Gabriele Peron
Abstract
Industry trends toward time to market and smaller batch sizes make new investment in large sterile manufacturing facilities difficult to justify. Production spaces need design that incorporate the flexibility required for the new business models. Concurrently, facility aging combined with increasingly challenging GMP requirements are driving the need for new technologies. These technologies include single-use product contact components, presterilized container/closures and increased use of robotics in processing. The integration of engineering design, business needs and supplier technologies will help the next generation of sterile manufacturing facilities. At the same time, there is a clear need to increase sterility assurance levels, increase productivity and get a faster access to market, with reduced investments as urgent priorities. This paper illustrates the direct impact on pharma manufacturing facility design due to the adoption of technologies based on the concept of ready to use platform.